Artiva Biotherapeutics Inc (ARTV)
11.96
+0.74
(+6.60%)
USD |
NASDAQ |
Nov 05, 16:00
11.96
0.00 (0.00%)
After-Hours: 20:00
Artiva Biotherapeutics Total Liabilities (Quarterly): 264.83M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 264.83M |
| March 31, 2022 | 261.24M |
| December 31, 2021 | 258.78M |
| Date | Value |
|---|---|
| September 30, 2021 | 257.44M |
| December 31, 2020 | 50.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.80M
Minimum
Dec 2020
264.83M
Maximum
Mar 2024
218.62M
Average
258.78M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.16M |
| Shareholders Equity (Quarterly) | -174.67M |
| Current Ratio | 6.355 |